NCT00979472View on ClinicalTrials.gov

Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency

PHASE4CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Urinary Bladder, OveractiveOveractive Bladder
Interventions
DRUG

Solifenacin

oral

Trial Locations (9)

700-712

Daegu

705-718

Daegu

301-721

Daejeon

400-711

Inchon

519-809

Jeonnam

602-739

Pusan

135-170

Seoul

135-705

Seoul

138-736

Seoul

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Asan Medical Center

OTHER

NCT00979472 - Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency | Biotech Hunter | Biotech Hunter